Daxor Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Daxor

Access the complete profile.

Daxor Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	334516 Analytical Laboratory Instrument Manufacturing
Additional NAICS Codes	339112 Surgical & Medical Instrument Manufacturing
Address	350 5th Ave Ste 4740 New York, NY 10118

Daxor's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Daxor's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Daxor is classified as operating in the Analytical Laboratory Instrument Manufacturing industry, NAICS Code 334516.

Daxor is a publicly traded company on ASE using the ticker symbol DXR. Detailed information on company financials and operating reports can be found here: ASE: DXR

Daxor Annual Revenue and Growth Rate

Daxor	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Daxor's revenues are gauged from an analysis of company filings.

Trademark Applications

Trademark applications show the products and services that Daxor is developing and marketing. Daxor doesn't have any recent trademark applications, indicating Daxor is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
VOLUMEX-OK Diagnostic kits comprising radiopharmaceutical preparations for measurement of blood, plasma and red cell volume for clinical or medical laboratory use	03/08/2012
VOLUMEX diagnostic kits comprising radiopharmaceutical preparations for measurement of blood, plasma and red cell volume for clinical or medical laboratory use	10/25/2004

See all trademarks and details in the Full Report.

Market Share of Daxor's Largest Competitors

A competitive analysis shows these companies are in the same general field as Daxor, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
VERISK ANALYTICS	Jersey City, NJ	100
WATERS	Milford, MA	91
METER GROUP INC. USA	Coeur D Alene, ID	3
UNCHAINED LABS	Pleasanton, CA	3
NANOSCIENCE ANALYTICAL	Phoenix, AZ	2
ARTEL	Westbrook, ME	1
MICROTRAC	York, PA	1
PION	Billerica, MA	1
TRAJAN SCIENTIFIC AMERICAS	Pflugerville, TX	1

Nearby Competitors

These companies are similar in business line and location to Daxor. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
RAYSEARCH AMERICAS	New York, NY	100
DAXOR	New York, NY	46
ASCENTIVE	New York, NY	5
ASTROHAUS	New York, NY	3

Future Competition: Daxor's Fastest Growing Competitors

These companies are in the same general field as Daxor and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)